Sanofi’s $300m plans for India vaccine plant

by Emma 6. October 2011 16:01


Sanofi Pasteur has invested $300 million in plans to open a new vaccine manufacturing plant in India by March 2012.

The new plant aims to help expand the company’s vaccine capabilities, following the acquisition of India’s Shantha Biotech for $784 million in 2009.

However, the deal carried manufacturing defects forced by the WHO to cancel pre-qualification of the vaccine Shan5, costing Sanofi hundreds of millions of dollars.

But Chris Viehbacher, CEO of Sanofi, said to the Business Standard: “We have implemented all the corrective measures. And we are quite positive about the relationship with Shantha and will be participating in global tenders once the pre-qualification process is completed for low-cost and high-quality vaccines.”

By 2015, Sanofi expects 30% of its total sales to come from the US, 33% from Europe and the rest from emerging markets.


11/23/2011 2:00:36 PM #

Piedad Fabela

Your writing is greatSmile

Piedad Fabela United States

11/24/2011 3:32:46 AM #

Metodo Gabriel

Noticed your site on delicious right now and genuinely enjoyed it.. Such a type of blog post will definitely click to numerous viewers. A good article and useful for its written content. Many thanks for sharing it up!

Metodo Gabriel United States

11/24/2011 7:56:53 PM #

Sterling Silver Jewelry

Your blog is a good place to catch news, indeed. Well done!

Sterling Silver Jewelry United States

12/2/2011 4:27:20 AM #


Hey, you used to write fantastic, but the last several posts have been kinda boring? I miss your tremendous writings. Past few posts are just a little bit out of track! come on!

Sukienka United States

12/30/2011 7:43:56 AM #

ratownik medyczny

yeah bookmaking this wasn't a  risky  decision   outstanding post! .

ratownik medyczny United States

Comments are closed


Tag cloud


<<  May 2018  >>

View posts in large calendar

Month List